IPO Pipeline Update: Two New Filings, BKV Amends Prospectus

NEW FILINGS 

Company: BKV Corporation
Symbol: BKV (NYSE)
Description: They are a forward thinking, growth driven energy company focused on creating value for our stockholders through the organic development of our properties as well as accretive acquisitions.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Credit Suisse, BofA Securities, Barclays, Citigroup, Evercore ISI, Jefferies
Co-Manager(s): TPH & Co., Susquehanna Financial Group, SMBC Nikko
Link to Prospectus: Amended Prospectus: 06-26-23

Company: Sagimet Biosciences Inc.
Symbol: SGMT
Description: They are a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic pathways in diseases resulting from the overproduction of the fatty acid, palmitate.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, Cowen, Piper Sandler
Co-Manager(s): JMP Securities
Link to Prospectus: Filing 6-24-23
Originally filed in April 2021

Company: ODDITY Tech Ltd.
Symbol: ODD (Nasdaq)
Description: They are a consumer tech platform that is built to transform the global beauty and wellness market.
Shares: TBD
Price Range: TBD
Market Cap: TBD
Trade Date: TBD
Underwriters: ​ Goldman Sachs, Morgan Stanley, Allen & Co., BofA Securities, Barclays, Truist Securities, JMP Securities, KeyBanc Capital
Link to Prospectus: Filed: 06-23-23

TERMS ADDED

NONE AT THIS TIME